• Fund Type: Open-End Fund
  • Objective: Health Care Sector
  • Asset Class: Equity
  • Geographic Focus: U.S.

Delaware Healthcare Fund

+ Add to Watchlist

DLHAX:US

20.33 USD 0.03 0.15%

As of 09:29:30 ET on 10/22/2014.

Snapshot for Delaware Healthcare Fund (DLHAX)

Year To Date: +12.76% 3-Month: -0.97% 3-Year: +26.38% 52-Week Range: 16.90 - 21.19
1-Month: -2.54% 1-Year: +16.02% 5-Year: +21.15% Beta vs RGUSH: 0.97

Mutual Fund Chart for DLHAX

No chart data available.
  • DLHAX:US 20.33
  • 1M
  • 1Y
Interactive DLHAX Chart

Previous Close

No chart data available.
Interactive Chart
  • 1W
  • 1M
  • YTD
  • 1Y
  • 3Y
  • 5Y
Close:
Open:
High:
Low:
Volume:
Recently Viewed Symbols
Save as Watchlist
Saving as watchlist...

Fund Profile & Information for DLHAX

Delaware Healthcare Fund is an open-end fund incorporated in the USA. The Fund's objective is to maximize long-term capital growth through capital appreciation. The Fund invests at least 80% of its assets in the equity securities of health care companies.

Inception Date: 09-28-2007 Telephone: 1-800-523-1918
Managers: LIU-ER CHEN "NU"
Web Site: www.delawareinvestments.com/co/delaware

Fundamentals for DLHAX

NAV (on 2014-10-22) 20.33
Assets (M) (on 2014-10-22) 424.33
Fund Leveraged N
Minimum Investment 1,000.00
Minimum Subsequent Investment 100.00

Dividends for DLHAX

Dividend Type Short Term Cap Gain
Dividend Frequency Annual
Last Dividend Net (on 2013-12-06) 0.32
Dividend Yield (ttm) 2.07

Fees & Expenses for DLHAX

Front Load 5.75
Back Load 0.00
Current Mgmt Fee 0.85
Redemption Fee 0.00
12b1 Fee 0.25
Expense Ratio 1.38

Top Fund Holdings for DLHAX

Filing Date: 08/29/2014
Name Position Value % of Total
Eli Lilly & Co 600,000 38,136,000 8.481%
GlaxoSmithKline PLC 538,000 26,415,800 5.875%
Teva Pharmaceutical Industries 500,000 26,260,000 5.840%
UCB SA 249,785 24,189,629 5.380%
Pfizer Inc 800,000 23,512,000 5.229%
WellPoint Inc 150,000 17,476,500 3.887%
Bristol-Myers Squibb Co 341,737 17,308,979 3.849%
Fresenius Medical Care AG & Co 230,000 16,220,147 3.607%
Chugai Pharmaceutical Co Ltd 488,300 15,462,481 3.439%
Boston Scientific Corp 1,100,000 13,948,000 3.102%

Quotes delayed, except where indicated otherwise. Mutual fund NAVs include dividends. All prices in local currency. Time is ET.

Sponsored Link
Advertisement
Advertisement
Sponsored Links
Advertisements
sec ||= nil